Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bayer asks trial judge to reverse $2 billion Roundup jury verdict

Published 06/18/2019, 01:13 PM
Updated 06/18/2019, 01:13 PM
© Reuters. Monsanto Co's Roundup shown for sale in California

By Tina Bellon

(Reuters) - Bayer AG (DE:BAYGN) has asked a California judge to overrule a $2 billion verdict by jurors who found the company's glyphosate-based Roundup weed killer responsible for a couple's cancer, arguing the jury decision was not supported by evidence.

The German drugmaker and chemicals company in court filings on Monday in Alameda County Superior Court in Oakland blamed the massive verdict on "inflammatory, fabricated and irrelevant evidence" from the couples' lawyers.

"The resulting trial focused not on ascertaining the truth regarding the state of the science, causation, and compliance with legal duties, but instead on vilifying Monsanto (NYSE:MON) in the abstract," the company, which bought Monsanto last year for $63 billion, said in motions filed with the court.

Bayer faces Roundup cancer lawsuits by more than 13,400 plaintiffs across the United States. It denies the allegations, saying the weed killer and its active ingredient glyphosate is safe for human use.

The verdict and two prior jury decisions against Bayer have triggered steep declines in Bayer shares, leaving it with a market valuation of $56 billion.

Bayer asked Superior Court Judge Winifred Smith, who presided over the roughly seven-week long trial, to reverse the jury decision and enter judgment in Bayer's favor, or order a new trial.

The Oakland jury on May 13 awarded more than $2 billion to Alva and Alberta Pilliod, finding their non-Hodgkin's lymphoma to have been caused by using Roundup to kill weeds on their property between 1975 and 2011.

The jury awarded $18 million in compensatory and $1 billion in punitive damages to Alva Pilliod, and $37 million in compensatory and $1 billion in punitive damages to his wife.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bayer in its court filings called the punitive damages excessive and unconstitutional, and asked Smith to toss or significantly reduce the award. The large punitive damages award is likely to be reduced due to U.S. Supreme Court rulings that limit the ratio of punitive to compensatory damages to 9:1.

Michael Miller, a lawyer for the Pilliods, in a statement on Tuesday said the verdict would be sustained.

"Monsanto is arguing the same worn out arguments it unsuccessfully used in the first trial," Miller said.  

In that trial, a California jury in 2018 awarded $289 million to a California groundskeeper, finding Monsanto's glyphosate-based weed killers caused his cancer. That award was later reduced to $78 million and being appealed.

In March, a federal jury in San Francisco awarded $80 million to another California man after finding Roundup caused his cancer. The company said it would appeal that decision.

Latest comments

reason would say reverse, $2 billion is a ridiculous settlement. speaks to the ignorance of juries.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.